Equity Analysis /
United States of America

US : Teva Pharmaceutical Industries Ltd. - TEVA | Weekly CGRP and Austedo Market Trends

    Lucas Lee
    Lucas Lee

    Sr. Res. Assoc.

    Follow
    CGS-CIMB
    19 January 2021
    Published byCGS-CIMB

    Updated product metrics based on weekly prescription trends for three key anti-CGRP products as well as Teva’s Austedo.Ajovy (Teva)Ajovy is in its 27th month of launch, and the latest weekly number in terms of TRx was 13,321, while Aimovig and Emgality have slowed over the past several months.Recei